The endocannabinoid system in normal and pathological brain ageing

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 367, Issue 1607, 2012, Pages 3326-3341

  Bilkei Gorzo, Andras ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Glial regulation; Macromolecule clearance; Neurodegenerative diseases; Neurogenesis; Neuroinflammation; Oxidative stress

Indexed keywords

EID: 84868131884     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2011.0388     Document Type: Review

References (266)

1. Seidler, R. D., Bernard, J. A., Burutolu, T. B., Fling, B. W., Gordon, M. T., Gwin, J. T., Kwak, Y. & Lipps, D. B. 2010 Motor control and aging: links to age-related brain structural, functional, and biochemical effects. Neurosci. Biobehav. Rev. 34, 721-733. (doi:10.1016/j.neubiorev.2009.10.005)
2. Baltes, P. B. & Lindenberger, U. 1997 Emergence of a powerful connection between sensory and cognitive functions across the adult life span: a new window to the study of cognitive aging? Psychol. Aging 12, 12-21. (doi:10.1037/0882-7974.12.1.12)
3. Glisky, E. L. 2007 Changes in cognitive function in human aging. In Brain aging models, methods, and mechanisms (ed. D. R. Riddle). New York, NY: CRC Press.
4. Rapp, P. R. & Amaral, D. G. 1989 Evidence for taskdependent memory dysfunction in the aged monkey. J. Neurosci. 9, 3568-3576.
5. (-/-) mice. Neurobiol. Aging 33, e11-e22. (doi:10.1016/j.neurobiolaging.2010.07.009)
6. Yu, L., Tucci, V., Kishi, S. & Zhdanova, I. V. 2006 Cognitive aging in zebrafish. PLoS ONE 1, e14. (doi:10.1371/journal.pone.0000014)
7. Eyler, L. T., Sherzai, A., Kaup, A. R. & Jeste, D. V. 2011 A review of functional brain imaging correlates of successful cognitive aging. Biol. Psychiatry 70, 115-122. (doi:10.1016/j.biopsych.2010.12.032)
8. Double, K. L., Reyes, S., Werry, E. L. & Halliday, G. M. 2010 Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions? Prog. Neurobiol. 92, 316-329. (doi:10.1016/j.pneurobio.2010.06.001)
9. Small, S. A., Schobel, S. A., Buxton, R. B., Witter, M. P. & Barnes, C. A. 2011 A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat. Rev. Neurosci. 12, 585-601. (doi:10.1038/nrn3085)
10. Bano, D., Agostini, M., Melino, G. & Nicotera, P. 2011 Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect. Mol. Neurobiol. 43, 124-130. (doi:10.1007/s12035-011-8164-6)
11. Mattson, M. P. 2007 Calcium and neurodegeneration. Aging Cell 6, 337-350. (doi:10.1111/j.1474-9726.2007.00275.x)
12. Fjell, A. M. & Walhovd, K. B. 2010 Structural brain changes in aging: courses, causes and cognitive consequences. Rev. Neurosci. 21, 187-221. (doi:10.1515/REVNEURO.2010.21.3.187)
13. Jernigan, T. L. & Gamst, A. C. 2005 Changes in volume with age-consistency and interpretation of observed effects. Neurobiol. Aging 26, 1271-1274; discussion 1275-8. (doi:10.1016/j.neurobiolaging.2005.05.016)
14. Bartzokis, G., Sultzer, D., Lu, P. H., Nuechterlein, K. H., Mintz, J. & Cummings, J. L. 2004 Heterogeneous agerelated breakdown of white matter structural integrity: implications for cortical 'disconnection' in aging and Alzheimer's disease. Neurobiol. Aging 25, 843-851. (doi:10.1016/j.neurobiolaging.2003.09.005)
15. Marner, L., Nyengaard, J. R., Tang, Y. & Pakkenberg, B. 2003 Marked loss of myelinated nerve fibers in the human brain with age. J. Comp. Neurol. 462, 144-152. (doi:10.1002/cne.10714)
16. Salthouse, T. A. 2011 Neuroanatomical substrates of age-related cognitive decline. Psychol. Bull. 137, 753-784. (doi:10.1037/a0023262)
17. Pakkenberg, B., Pelvig, D., Marner, L., Bundgaard, M. J., Gundersen, H. J., Nyengaard, J. R. & Regeur, L. 2003 Aging and the human neocortex. Exp. Gerontol. 38, 95-99. (doi:10.1016/S0531-5565(02)00151-1)
18. Pakkenberg, B. & Gundersen, H. J. 1997 Neocortical neuron number in humans: effect of sex and age. J. Comp. Neurol. 384, 312-320. (doi:10.1002/(SICI)1096-9861(19970728)384:2,312::AID-CNE10.3.0.CO;2-K)
19. West, M. J. 1993 Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 14, 287-293. (doi:10.1016/0197-4580(93)90113-P)
20. Simic, G., Bexheti, S., Kelovic, Z., Kos, M., Grbic, K., Hof, P. R. & Kostovic, I. 2005 Hemispheric asymmetry, modular variability and age-related changes in the human entorhinal cortex. Neuroscience 130, 911-925. (doi:10.1016/j.neuroscience.2004.09.040)
21. Kordower, J. H., Chu, Y., Stebbins, G. T., DeKosky, S. T., Cochran, E. J., Bennett, D. & Mufson, E. J. 2001 Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann. Neurol. 49, 202-213. (doi:10.1002/1531-8249(20010201)49:2,202::AID-ANA40.3.0.CO;2-3)
22. Couillard-Despres, S., Iglseder, B. & Aigner, L. 2011 Neurogenesis, cellular plasticity and cognition: the impact of stem cells in the adult and aging brain: a mini-review. Gerontology 57, 559-564. (doi:10.1159/000323481)
23. Yassa, M. A. & Stark, C. E. 2011 Pattern separation in the hippocampus. Trends Neurosci. 34, 515-525. (doi:10.1016/j.tins.2011.06.006)
24. Burke, S. N. & Barnes, C. A. 2006 Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 7, 30-40. (doi:10.1038/nrn1809)
25. Pannese, E. 2011 Morphological changes in nerve cells during normal aging. Brain Struct. Funct. 216, 85-89. (doi:10.1007/s00429-011-0308-y)
26. Flood, D. G. 1993 Critical issues in the analysis of dendritic extent in aging humans, primates, and rodents. Neurobiol. Aging 14, 649-654. (doi:10.1016/0197-4580(93)90058-J)
27. Grill, J. D. & Riddle, D. R. 2002 Age-related and laminar- specific dendritic changes in the medial frontal cortex of the rat. Brain Res. 937, 8-21. (doi:10.1016/S0006-8993(02)02457-5)
28. Ginsberg, S. D. 2007 Expression profile analysis of brain aging. In Brain aging models methods, and mechanisms (ed. D. R. Riddle), pp. 159-185. Boca Raton, FL: CRC Press.
29. Lonze, B. E. & Ginty, D. D. 2002 Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623. (doi:10.1016/S0896-6273(02)00828-0)
30. Saura, C. A. & Valero, J. 2011 The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev. Neurosci. 22, 153-169. (doi:10.1515/rns.2011.018)
31. Chen, G., Zou, X., Watanabe, H., van Deursen, J. M. & Shen, J. 2010 CREB binding protein is required for both short-term and long-term memory formation. J. Neurosci. 30, 13066-13077. (doi:10.1523/JNEUROSCI.2378-10.2010)
32. Menard, C. & Quirion, R. 2012 Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS ONE 7, e28666. (doi:10.1371/journal.pone.0028666)
33. Ljungberg, M. C., Ali, Y. O., Zhu, J., Wu, C. S., Oka, K., Zhai, R.G. & Lu, H. C. 2012 CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, whileNMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Hum. Mol. Genet. 21, 251-267. (doi:10.1093/hmg/ddr492)
34. Ma, Q. L., Harris-White, M. E., Ubeda, O. J., Simmons, M., Beech, W., Lim, G. P., Teter, B., Frautschy, S. A. & Cole, G. M. 2007 Evidence of Abeta- and transgenedependent defects in ERK-CREB signaling in Alzheimer's models. J. Neurochem. 103, 1594-1607. (doi:10.1111/j.1471-4159.2007.04869.x)
35. Tomobe, K., Okuma, Y. & Nomura, Y. 2007 Impairment of CREB phosphorylation in the hippocampal CA1 region of the senescence-accelerated mouse (SAM) P8. Brain Res. 1141, 214-217. (doi:10.1016/j.brainres.2006.08.026)
36. Monti, B., Berteotti, C. & Contestabile, A. 2005 Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment. Hippocampus 15, 1041-1049. (doi:10.1002/hipo.20099)
37. Porte, Y., Buhot, M. C. & Mons, N. 2008 Alteration of CREB phosphorylation and spatial memory deficits in aged 129T2/Sv mice. Neurobiol. Aging 29, 1533-1546. (doi:10.1016/j.neurobiolaging.2007.03.023)
38. Mair, W., Morantte, I., Rodrigues, A. P., Manning, G., Montminy, M., Shaw, R. J. & Dillin, A. 2011 Lifespan extension induced byAMPKand calcineurin is mediated by CRTC-1 and CREB. Nature 470, 404-408. (doi:10.1038/nature09706)
39. Zhang, M., Poplawski, M., Yen, K., Cheng, H., Bloss, E., Zhu, X., Patel, H. & Mobbs, C. V. 2009 Role of CBP and SATB-1 in aging, dietary restriction, and insulin-like signaling. PLoS Biol. 7, e1000245. (doi:10.1371/journal.pbio.1000245)
40. 2+ and mitochondria as substrates for deficits in synaptic plasticity in normal brain ageing. J. Cell Mol. Med. 8, 181-190. (doi:10.1111/j.1582-4934.2004.tb00273.x)
41. Thibault, O. & Landfield, P. W. 1996 Increase in single L-type calcium channels in hippocampal neurons during aging. Science 272, 1017-1020. (doi:10.1126/science.272.5264.1017)
42. Michaelis, M. L. et al. 1996 Decreased plasma membrane calcium transport activity in aging brain. Life Sci. 59, 405-412. (doi:10.1016/0024-3205(96)00319-0)
43. Zaidi, A., Gao, J., Squier, T. C. & Michaelis, M. L. 1998 Age-related decrease in brain synaptic membrane Ca2+-ATPase in F344/BNF1 rats. Neurobiol. Aging 19, 487-495. (doi:10.1016/S0197-4580(98)00078-5)
44. Bu, J., Sathyendra, V., Nagykery, N. & Geula, C. 2003 Age-related changes in calbindin-D28k, calretinin, and parvalbumin-immunoreactive neurons in the human cerebral cortex. Exp. Neurol. 182, 220-231. (doi:10.1016/S0014-4886(03)00094-3)
45. 2+ regulation and gene expression in normal brain aging. Trends Neurosci. 27, 614-620. (doi:10.1016/j.tins.2004.07.010)
46. Bishop, N. A., Lu, T. & Yankner, B. A. 2010 Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535. (doi:10.1038/nature08983)
47. Lu, T., Pan, Y., Kao, S. Y., Li, C., Kohane, I., Chan, J. & Yankner, B. A. 2004 Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891. (doi:10.1038/nature02661)
48. Lee, C. K., Weindruch, R. & Prolla, T. A. 2000 Gene-expression profile of the ageing brain in mice. Nat. Genet. 25, 294-297. (doi:10.1038/77046)
49. Zhan, M., Yamaza, H., Sun, Y., Sinclair, J., Li, H. & Zou, S. 2007 Temporal and spatial transcriptional profiles of aging in Drosophila melanogaster. Genome Res. 17, 1236-1243. (doi:10.1101/gr.6216607)
50. Kang, H. J. et al. 2011 Spatio-temporal transcriptome of the human brain. Nature 478, 483-489. (doi:10.1038/nature10523)
51. Jiang, C. H., Tsien, J. Z., Schultz, P. G. & Hu, Y. 2001 The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl Acad. Sci. USA 98, 1930-1934. (doi:10.1073/pnas.98.4.1930)
52. Blalock, E. M., Chen, K. C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C. & Landfield, P. W. 2003 Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J. Neurosci. 23, 3807-3819.
53. Burger, C., Lopez, M. C., Feller, J. A., Baker, H. V., Muzyczka, N. & Mandel, R. J. 2007 Changes in transcription within the CA1 field of the hippocampus are associated with age-related spatial learning impairments. Neurobiol. Learn. Mem. 87, 21-41. (doi:10.1016/j.nlm.2006.05.003)
54. Stranahan, A. M., Lee, K., Becker, K. G., Zhang, Y., Maudsley, S., Martin, B., Cutler, R. G. & Mattson, M. P. 2010 Hippocampal gene expression patterns underlying the enhancement of memory by running in aged mice. Neurobiol. Aging 31, 1937-1949. (doi:10.1016/j.neurobiolaging.2008.10.016)
55. Swanson, K. S., Vester, B. M., Apanavicius, C. J., Kirby, N. A. & Schook, L. B. 2009 Implications of age and diet on canine cerebral cortex transcription. Neurobiol. Aging 30, 1314-1326. (doi:10.1016/j.neurobiolaging.2007.10.017)
56. Haberman, R. P., Colantuoni, C., Stocker, A. M., Schmidt, A. C., Pedersen, J. T. & Gallagher, M. 2011 Prominent hippocampal CA3 gene expression profile in neurocognitive aging. Neurobiol. Aging 32, 1678-1692. (doi:10.1016/j.neurobiolaging.2009.10.005)
57. Kopra, O. et al. 2004 A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum. Mol. Genet. 13, 2893-2906. (doi:10.1093/hmg/ddh312)
58. Ricciarelli, R., d'Abramo, C., Massone, S., Marinari, U., Pronzato, M. & Tabaton, M. 2004 Microarray analysis in Alzheimer's disease and normal aging. IUBMB Life 56, 349-354. (doi:10.1080/15216540 412331286002)
59. Wu, Z. L., Ciallella, J. R., Flood, D. G., O'Kane, T. M., Bozyczko-Coyne, D. & Savage, M. J. 2006 Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 27, 377-386. (doi:10.1016/j.neurobiolaging.2005.02.010)
60. Cheung, I., Shulha, H.P., Jiang, Y., Matevossian, A., Wang, J., Weng, Z. & Akbarian, S. 2010 Developmental regulation and individual differences of neuronal H3K4me3 epigenomes in the prefrontal cortex. Proc. Natl Acad. Sci. USA 107, 8824-8829. (doi:10.1073/pnas.1001702107)
61. Moroz, L. L. & Kohn, A. B. 2010 Do different neurons age differently? Direct genome-wide analysis of aging in single identified cholinergic neurons. Front. Aging Neurosci. 2, 6. (doi:10.3389/neuro.24.006.2010)
62. Peleg, S. et al. 2010 Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 328, 753-756. (doi:10.1126/science.1186088)
63. Gemma, C., Vila, J., Bachstetter, A. & Bickford, P. C. 2007 Oxidative stress and the aging brain: from theory to prevention. In Brain aging: models, methods, and mechanisms (ed. D. R. Riddle), pp. 353-374. Boca Raton, FL: CRC Press.
64. Genova, M. L. et al. 2004 The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann. NY Acad. Sci. 1011, 86-100. (doi:10.1196/annals.1293.010)
65. Serrano, F. & Klann, E. 2004 Reactive oxygen species and synaptic plasticity in the aging hippocampus. Ageing Res. Rev. 3, 431-443. (doi:10.1016/j.arr.2004.05.002)
66. Saxena, S. & Caroni, P. 2011 Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71, 35-48. (doi:10.1016/j.neuron.2011.06.031)
67. Sedensky, M. M. & Morgan, P. G. 2006 Mitochondrial respiration and reactive oxygen species in mitochondrial aging mutants. Exp. Gerontol. 41, 237-245. (doi:10.1016/j.exger.2006.01.004)
68. Fraser, H. B., Khaitovich, P., Plotkin, J. B., Paabo, S. & Eisen, M. B. 2005 Aging and gene expression in the primate brain. PLoS Biol. 3, e274. (doi:10.1371/journal.pbio.0030274)
69. Sasaki, T., Unno, K., Tahara, S., Shimada, A., Chiba, Y., Hoshino, M. & Kaneko, T. 2008 Age-related increase of superoxide generation in the brains of mammals and birds. Aging Cell 7, 459-469. (doi:10.1111/j.1474-9726.2008.00394.x)
70. Yankner, B. A., Lu, T. & Loerch, P. 2008 The aging brain. Annu. Rev. Pathol. 3, 41-66. (doi:10.1146/annurev.pathmechdis.2.010506.092044)
71. Toescu, E. C. 2005 Normal brain ageing: models and mechanisms. Phil. Trans. R. Soc. B 360, 2347-2354. (doi:10.1098/rstb.2005.1771)
72. Floyd, R. A. & Hensley, K. 2002 Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795-807. (doi:10.1016/S0197-4580(02)00019-2)
73. Grimm, S., Hoehn, A., Davies, K. J. & Grune, T. 2011 Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic. Res. 45, 73-88. (doi:10.3109/10715762.2010.512040)
74. Korolainen, M. A., Goldsteins, G., Nyman, T. A., Alafuzoff, I., Koistinaho, J. & Pirttila, T. 2006 Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol. Aging 27, 42-53. (doi:10.1016/j.neurobiolaging.2004.11.010)
75. Pratico, D. 2008 Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. NY Acad. Sci. 1147, 70-78. (doi:10.1196/annals.1427.010)
76. Nunomura, A. et al. 2012 The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J. Neuropathol. Exp. Neurol. 71, 233-241. (doi:10.1097/NEN.0b013e318248e614)
77. Du, H., Guo, L., Yan, S., Sosunov, A. A., McKhann, G. M. & Yan, S. S. 2010 Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl Acad. Sci. USA 107, 18670-18675. (doi:10.1073/pnas.1006586107)
78. Lee, H. P., Pancholi, N., Esposito, L., Previll, L. A., Wang, X., Zhu, X., Smith, M. A. & Lee, H. G. 2012 Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS ONE 7, e28033. (doi:10.1371/journal.pone.0028033)
79. McManus, M. J., Murphy, M. P. & Franklin, J. L. 2011 The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 31, 15703-15715. (doi:10.1523/JNEUROSCI.0552-11.2011)
80. Guzman, J. N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P. T. & Surmeier, D. J. 2010 Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696-700. (doi:10.1038/nature09536)
81. Venkateshappa, C., Harish, G., Mythri, R. B., Mahadevan, A., Bharath, M. M. & Shankar, S. K. 2012 Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson's disease. Neurochem. Res. 37, 358-369. (doi:10.1007/s11064-011-0619-7)
82. German, D. C., Manaye, K. F., White 3rd, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N. & Mann, D. M. 1992 Disease-specific patterns of locus coeruleus cell loss. Ann. Neurol. 32, 667-676. (doi:10.1002/ana.410320510)
83. Napolitano, A., Manini, P. & d'Ischia, M. 2011 Oxidation chemistry of catecholamines and neuronal degeneration: an update. Curr. Med. Chem. 18, 1832-1845. (doi:10.2174/092986711795496863)
84. Head, E. 2009 Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging. Neurochem. Res. 34, 670-678. (doi:10.1007/s11064-008-9808-4)
85. Lau, F. C., Shukitt-Hale, B. & Joseph, J. A. 2005 The beneficial effects of fruit polyphenols on brain aging. Neurobiol. Aging 26(Suppl. 1), 128-132. (doi:10.1016/j.neurobiolaging.2005.08.007)
86. Melov, S. 2002 Therapeutics against mitochondrial oxidative stress in animal models of aging. Ann. NYAcad. Sci. 959, 330-340. (doi:10.1111/j.1749-6632.2002.tb02104.x)
87. Haxaire, C., Turpin, F. R., Potier, B., Kervern, M., Sinet, P. M., Barbanel, G., Mothet, J. P., Dutar, P. & Billard, J. M. 2012 Reversal of age-related oxidative stress prevents hippocampal synaptic plasticity deficits by protecting d-serine-dependent NMDA receptor activation. Aging Cell 11, 336-344. (doi:10.1111/j.1474-9726.2012.00792.x)
88. Liu, R., Liu, I. Y., Bi, X., Thompson, R. F., Doctrow, S. R., Malfroy, B. & Baudry, M. 2003 Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics Proc. Natl Acad. Sci. USA 100, 8526-8531. (doi:10.1073/pnas.1332809100)
89. Kolosova, N. G., Shcheglova, T. V., Sergeeva, S. V. & Loskutova, L. V. 2006 Long-term antioxidant supplementation attenuates oxidative stress markers and cognitive deficits in senescent-accelerated OXYS rats. Neurobiol. Aging 27, 1289-1297. (doi:10.1016/j.neurobiolaging.2005.07.022)
90. Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P. & Murphy, T. H. 2005 Induction of the Nrf2- driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280, 22925-22936. (doi:10.1074/jbc.M414635200)
91. Esposito, E., Rotilio, D., Di Matteo, V., Di Giulio, C., Cacchio, M. & Algeri, S. 2002 A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging 23, 719-735. (doi:10.1016/S0197-4580(02)00078-7)
92. Kumar, A., Dogra, S. & Prakash, A. 2009 Effect of carvedilol on behavioral, mitochondrial dysfunction, and oxidative damage against D-galactose induced senescence in mice. Naunyn Schmiedebergs Arch. Pharmacol. 380, 431-441. (doi:10.1007/s00210-009-0442-8)
93. Peng, Y., Sun, J., Hon, S., Nylander, A.N., Xia, W., Feng, Y., Wang, X. & Lemere, C. A. 2010 L-3-n-butylphthalide improves cognitive impairment and reduces amyloidbeta in a transgenic model of Alzheimer's disease. J. Neurosci. 30, 8180-8189. (doi:10.1523/JNEUROSCI.0340-10.2010)
94. Yokota, T. et al. 2001 Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proc. Natl Acad. Sci. USA 98, 15185-15190. (doi:10.1073/pnas.261456098)
95. Lipinski, M. M. et al. 2010 Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc. Natl Acad. Sci. USA 107, 14164-14169. (doi:10.1073/pnas.1009485107)
96. West, R. J. & Sweeney, S. T. 2012 Oxidative stress and autophagy: mediators of synapse growth? Autophagy 8, 284-285. (doi:10.4161/auto.8.2.18981)
97. Hardy, J. & Selkoe, D. J. 2002 The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (doi:10.1126/science.1072994)
98. Chu, Y. & Kordower, J. H. 2007 Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease? Neurobiol. Dis. 25, 134-149. (doi:10.1016/j.nbd.2006.08.021)
99. Lee, S. J., Lim, H. S., Masliah, E. & Lee, H. J. 2011 Protein aggregate spreading in neurodegenerative diseases: problems and perspectives. Neurosci. Res. 70, 339-348. (doi:10.1016/j.neures.2011.05.008)
100. Casarejos, M. J., Solano, R. M., Rodriguez-Navarro, J. A., Gomez, A., Perucho, J., Castano, J. G., Garcia de Yebenes, J. & Mena, M. A. 2009 Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis. J. Neurochem. 110, 1523-1537. (doi:10.1111/j.1471-4159.2009.06248.x)
101. Nakanishi, H. 2003 Neuronal and microglial cathepsins in aging and age-related diseases. Ageing Res. Rev. 2, 367-381. (doi:10.1016/S1568-1637(03)00027-8)
102. Pandey, U. B. et al. 2007 HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 447, 859-863. (doi:10.1038/nature05853)
103. Caballero, B. & Coto-Montes, A. 2012 An insight into the role of autophagy in cell responses in the aging and neurodegenerative brain. Histol. Histopathol. 27, 263-275.
104. Ling, D. & Salvaterra, P. M. 2011 Brain aging and Abeta neurotoxicity converge via deterioration in autophagy-lysosomal system: a conditional Drosophila model linking Alzheimer's neurodegeneration with aging. Acta Neuropathol. 121, 183-191. (doi:10.1007/s00401-010-0772-0)
105. Walter, S. et al. 2011 A genome-wide association study of aging. Neurobiol. Aging 32, 2109 e15-e28.
106. Rubinsztein, D. C., Marino, G. & Kroemer, G. 2011 Autophagy and aging. Cell 146, 682-695. (doi:10.1016/j.cell.2011.07.030)
107. Crowe, E., Sell, C., Thomas, J. D., Johannes, G. J. & Torres, C. 2009 Activation of proteasome by insulinlike growth factor-I may enhance clearance of oxidized proteins in the brain. Mech. Ageing Dev. 130, 793-800. (doi:10.1016/j.mad.2009.10.005)
108. Medina, D. X., Caccamo, A. & Oddo, S. 2011 Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol. 21, 140-149. (doi:10.1111/j.1750-3639.2010.00430.x)
109. Cooper, J. D., Messer, A., Feng, A. K., Chua-Couzens, J. & Mobley, W. C. 1999 Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J. Neurosci. 19, 2556-2567.
110. Poulose, S. M., Bielinski, D. F., Carrihill-Knoll, K., Rabin, B. M. & Shukitt-Hale, B. 2011 Exposure to 16O-particle radiation causes aging-like decrements in rats through increased oxidative stress, inflammation and loss of autophagy. Radiat. Res. 176, 761-769. (doi:10.1667/RR2605.1)
111. Komatsu, M. et al. 2006 Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884. (doi:10.1038/nature04723)
112. Qin, A. P., Zhang, H. L. & Qin, Z. H. 2008 Mechanisms of lysosomal proteases participating in cerebral ischemia-induced neuronal death. Neurosci. Bull. 24, 117-123. (doi:10.1007/s12264-008-0117-3)
113. Wang, Y., Dong, X. X., Cao, Y., Liang, Z. Q., Han, R., Wu, J. C., Gu, Z. L. & Qin, Z. H. 2009 P53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms. Eur. J. Neurosci. 30, 2258-2270. (doi:10.1111/j.1460-9568.2009.07025.x)
114. Wen, Y. D., Sheng, R., Zhang, L. S., Han, R., Zhang, X., Zhang, X. D., Han, F., Fukunaga, K. & Qin, Z. H. 2008 Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways. Autophagy 4, 762-769.
115. Harris, H. & Rubinsztein, D. C. 2011 Control of autophagy as a therapy for neurodegenerative disease. Nat. Rev. Neurol. 8, 108-117. (doi:10.1038/nrneurol.2011.200)
116. Kaunzner, U. W., Miller, M. M., Gottfried-Blackmore, A., Gal-Toth, J., Felger, J. C., McEwen, B. S. & Bulloch, K. 2012 Accumulation of resident and peripheral dendritic cells in the aging CNS. Neurobiol. Aging 33, 681-693. (doi:10.1016/j.neurobiolaging.2010.06.007)
117. Schuitemaker, A. et al. 2010 Microglial activation in healthy aging. Neurobiol. Aging 33, 1067-1072. (doi:10.1016/j.neurobiolaging.2010.09.016)
118. Agulhon, C., Petravicz, J., McMullen, A. B., Sweger, E. J., Minton, S. K., Taves, S. R., Casper, K. B., Fiacco, T. A. & McCarthy, K. D. 2008 What is the role of astrocyte calcium in neurophysiology? Neuron 59, 932-946. (doi:10.1016/j.neuron.2008.09.004)
119. Streit, W. J. 2005 Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res. Brain Res. Rev. 48, 234-239. (doi:10.1016/j.brainresrev.2004.12.013)
120. Castro, M. A., Beltran, F. A., Brauchi, S. & Concha, I. I. 2009 A metabolic switch in brain: glucose and lactate metabolism modulation by ascorbic acid. J. Neurochem. 110, 423-440. (doi:10.1111/j.1471-4159.2009.06151.x)
121. Petzold, G. C. & Murthy, V. N. 2011 Role of astrocytes in neurovascular coupling. Neuron 71, 782-797. (doi:10.1016/j.neuron.2011.08.009)
122. Bacci, A., Verderio, C., Pravettoni, E. & Matteoli, M. 1999 The role of glial cells in synaptic function. Phil. Trans. R. Soc. Lond. B 354, 403-409. (doi:10.1098/rstb.1999.0393)
123. Ferron, S. R. et al. 2011 Postnatal loss of Dlk1 imprinting in stem cells and niche astrocytes regulates neurogenesis. Nature 475, 381-385. (doi:10.1038/nature10229)
124. Gemma, C., Bachstetter, A. D. & Bickford, P. C. 2010 Neuron-microglia dialogue and hippocampal neurogenesis in the aged brain. Aging Dis. 1, 232-244.
125. Hanisch, U. K. & Kettenmann, H. 2007 Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. (doi:10.1038/nn1997)
126. Lucin, K. M. & Wyss-Coray, T. 2009 Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110-122. (doi:10.1016/j.neuron.2009.08.039)
127. Tremblay, M. E., Stevens, B., Sierra, A., Wake, H., Bessis, A. & Nimmerjahn, A. 2011 The role of microglia in the healthy brain. J. Neurosci. 31, 16064-16069. (doi:10.1523/JNEUROSCI.4158-11.2011)
128. Finch, C. E. 2010 Evolution in health and medicine Sackler colloquium: evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition. Proc. Natl Acad. Sci. USA 107(Suppl. 1), 1718-1724. (doi:10.1073/pnas.0909606106)
129. Villeda, S. A. et al. 2011 The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94. (doi:10.1038/nature10357)
130. Katsel, P., Tan, W. & Haroutunian, V. 2009 Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals. PLoS ONE 4, e7642. (doi:10.1371/journal.pone.0007642)
131. Lynch, A. M., Murphy, K. J., Deighan, B. F., O'Reilly, J. A., Gun'ko, Y. K., Cowley, T. R., Gonzalez-Reyes, R. E. & Lynch, M. A. 2010 The impact of glial activation in the aging brain. Aging Dis. 1, 262-278.
132. Naert, G. & Rivest, S. 2011 CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J. Neurosci. 31, 6208-6220. (doi:10.1523/JNEUROSCI.0299-11.2011)
133. Moriyama, M. et al. 2011 Complement receptor 2 is expressed in neural progenitor cells and regulates adult hippocampal neurogenesis. J. Neurosci. 31, 3981-3989. (doi:10.1523/JNEUROSCI.3617-10.2011)
134. Russo, I., Barlati, S. & Bosetti, F. 2011 Effects of neuroinflammation on the regenerative capacity of brain stem cells. J. Neurochem. 116, 947-956. (doi:10.1111/j.1471-4159.2010.07168.x)
135. Lynch, M. A. 2010 Age-related neuroinflammatory changes negatively impact on neuronal function. Front. Aging Neurosci. 1, 1-8.
136. Tha, K. K., Okuma, Y., Miyazaki, H., Murayama, T., Uehara, T., Hatakeyama, R., Hayashi, Y. & Nomura, Y. 2000 Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885, 25-31. (doi:10.1016/S0006-8993(00)02883-3)
137. Perry, V. H., Nicoll, J. A. & Holmes, C. 2010 Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193-201. (doi:10.1038/nrneurol.2010.17)
138. Lue, L. F., Kuo, Y. M., Beach, T. & Walker, D. G. 2010 Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol. Neurobiol. 41, 115-128. (doi:10.1007/s12035-010-8106-8)
139. Sardi, F., Fassina, L., Venturini, L., Inguscio, M., Guerriero, F., Rolfo, E. & Ricevuti, G. 2011 Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun. Rev. 11, 149-153. (doi:10.1016/j.autrev.2011.09.005)
140. Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C. & Wharton, S. B. 2010 Astrocyte phenotype in relation to Alzheimer- type pathology in the ageing brain. Neurobiol. Aging 31, 578-590. (doi:10.1016/j.neurobiolaging.2008.05.015)
141. Bradford, J., Shin, J. Y., Roberts, M., Wang, C. E., Li, X. J. & Li, S. 2009 Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc. Natl Acad. Sci. USA 106, 22480-22485. (doi:10.1073/pnas.0911503106)
142. Katsouri, L. & Georgopoulos, S. 2011 Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model. PLoS ONE 6, e21880. (doi:10.1371/journal.pone.0021880)
143. Klein, R. L., Dayton, R. D., Diaczynsky, C. G. & Wang, D. B. 2010 Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer. Neurobiol. Aging 31, 2091-2102. (doi:10.1016/j.neurobiolaging.2008.12.002)
144. Tress, O. et al. 2011 Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. PLoS Genet. 7, e1002146. (doi:10.1371/journal.pgen.1002146)
145. Campisi, J. 2005 Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522. (doi:10.1016/j.cell.2005.02.003)
146. Salminen, A., Ojala, J., Kaarniranta, K., Haapasalo, A., Hiltunen, M. & Soininen, H. 2011 Astrocytes in the aging brain express characteristics of senescenceassociated secretory phenotype. Eur. J. Neurosci. 34, 3-11. (doi:10.1111/j.1460-9568.2011.07738.x)
147. Garcia-Matas, S., Gutierrez-Cuesta, J., Coto-Montes, A., Rubio-Acero, R., Diez-Vives, C., Camins, A., Pallas, M., Sanfeliu, C. & Cristofol, R. 2008 Dysfunction of astrocytes in senescence-accelerated mice SAMP8 reduces their neuroprotective capacity. Aging Cell 7, 630-640. (doi:10.1111/j.1474-9726.2008.00410.x)
148. Nakanishi, H. & Wu, Z. 2009 Microglia-aging: roles of microglial lysosome- and mitochondria-derived reactive oxygen species in brain aging. Behav. Brain Res. 201, 1-7. (doi:10.1016/j.bbr.2009.02.001)
149. Luo, X. G., Ding, J. Q. & Chen, S. D. 2010 Microglia in the aging brain: relevance to neurodegeneration. Mol. Neurodegener. 5, 12. (doi:10.1186/1750-1326-5-12)
150. von Bernhardi, R., Tichauer, J. E. & Eugenin, J. 2010 Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J. Neurochem. 112, 1099-1114. (doi:10.1111/j.1471-4159.2009.06537.x)
151. Ron-Harel, N. & Schwartz, M. 2009 Immune senescence and brain aging: can rejuvenation of immunity reverse memory loss? Trends Neurosci. 32, 367-375. (doi:10.1016/j.tins.2009.03.003)
152. Hampson, R. E., Simeral, J. D., Kelly, E. J. & Deadwyler, S. A. 2003 Tolerance to the memory disruptive effects of cannabinoids involves adaptation by hippocampal neurons. Hippocampus 13, 543-556. (doi:10.1002/hipo.10081)
153. Mechoulam, R., Fride, E. & Di Marzo, V. 1998 Endocannabinoids. Eur. J. Pharmacol. 359, 1-18. (doi:10.1016/S0014-2999(98)00649-9)
154. Gallily, R., Breuer, A. & Mechoulam, R. 2000 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice. Eur. J. Pharmacol. 406, R5-R7. (doi:10.1016/S0014-2999(00)00653-1)
155. Nomura, D. K. et al. 2011 Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334, 809-813. (doi:10.1126/science.1209200)
156. Kessiova, M., Alexandrova, A., Georgieva, A., Kirkova, M. & Todorov, S. 2006 In vitro effects of CB1 receptor ligands on lipid peroxidation and antioxidant defense systems in the rat brain. Pharmacol. Rep. 58, 870-875.
157. Bobrov, M. Y., Lizhin, A. A., Andrianova, E. L., Gretskaya, N. M., Frumkina, L. E., Khaspekov, L. G. & Bezuglov, V. V. 2008 Antioxidant and neuroprotective properties of N-arachidonoyldopamine. Neurosci. Lett. 431, 6-11. (doi:10.1016/j.neulet.2007.11.010)
158. Marsicano, G., Moosmann, B., Hermann, H., Lutz, B. & Behl, C. 2002 Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J. Neurochem. 80, 448-456. (doi:10.1046/j.0022-3042.2001.00716.x)
159. Carracedo, A., Geelen, M. J., Diez, M., Hanada, K., Guzman, M. & Velasco, G. 2004 Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids. Biochem. J. 380, 435-440. (doi:10.1042/BJ20031714)
160. Garcia, C., Palomo-Garo, C., Garcia-Arencibia, M., Ramos, J., Pertwee, R. & Fernandez-Ruiz, J. 2011 Symptom-relieving and neuroprotective effects of the phytocannabinoid D-THCV in animal models of Parkinson's disease. Br. J. Pharmacol. 163, 1495-1506. (doi:10.1111/j.1476-5381.2011.01278.x)
161. Garcia-Arencibia, M., Gonzalez, S., de Lago, E., Ramos, J. A., Mechoulam, R. & Fernandez-Ruiz, J. 2007 Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptorindependent properties. Brain Res. 1134, 162-170. (doi:10.1016/j.brainres.2006.11.063)
162. Kim, H. J., Waataja, J. J. & Thayer, S. A. 2008 Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture. J. Pharmacol. Exp. Ther. 325, 850-858. (doi:10.1124/jpet.107.131607)
163. Goncharov, I., Weiner, L. & Vogel, Z. 2005 D9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress. Neuroscience 134, 567-574. (doi:10.1016/j.neuroscience.2005.04.042)
164. McKallip, R. J., Jia, W., Schlomer, J., Warren, J. W., Nagarkatti, P. S. & Nagarkatti, M. 2006 Cannabidiolinduced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol. Pharmacol. 70, 897-908. (doi:10.1124/mol.106.023937)
165. Giuliano, M., Calvaruso, G., Pellerito, O., Portanova, P., Carlisi, D., Vento, R. & Tesoriere, G. 2006 Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway. Int. J. Mol. Med. 17, 811-819.
166. Siegmund, S. V., Qian, T., de Minicis, S., Harvey-White, J., Kunos, G., Vinod, K. Y., Hungund, B. & Schwabe, R. F. 2007 The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J. 21, 2798-2806. (doi:10.1096/fj.06-7717com)
167. Brailoiu, G. C., Oprea, T. I., Zhao, P., Abood, M. E. & Brailoiu, E. 2011 Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide. J. Biol. Chem. 286, 29166-29174. (doi:10.1074/jbc.M110.217463)
168. Rozenfeld, R. & Devi, L. A. 2008 Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3. FASEB J. 22, 2311-2322. (doi:10.1096/fj.07-102731)
169. Noonan, J., Tanveer, R., Klompas, A., Gowran, A., McKiernan, J. & Campbell, V. A. 2010 Endocannabinoids prevent beta-amyloid-mediated lysosomal destabilization in cultured neurons. J. Biol. Chem. 285, 38543-38554. (doi:10.1074/jbc.M110.162040)
170. Gowran, A. & Campbell, V. A. 2008 A role for p53 in the regulation of lysosomal permeability by D9-tetrahydrocannabinol in rat cortical neurones: implications for neurodegeneration. J. Neurochem. 105, 1513-1524. (doi:10.1111/j.1471-4159.2008.05278.x)
171. Salazar, M. et al. 2009 Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J. Clin. Invest. 119, 1359-1372. (doi:10.1172/JCI37948)
172. Vara, D., Salazar, M., Olea-Herrero, N., Guzman, M., Velasco, G. & Diaz-Laviada, I. 2011 Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ. 18, 1099-1111. (doi:10.1038/cdd.2011.32)
173. Donadelli, M. et al. 2011 Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis. 2, e152. (doi:10.1038/cddis.2011.36)
174. Redlich, S., Ribes, S., Schutze, S., Czesnik, D. & Nau, R. 2012 Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 and Streptococcus pneumoniae R6 by microglial cells. J. Neuroimmunol. 244, 32-34. (doi:10.1016/j.jneuroim.2011.12.013)
175. Athanasiou, A. et al. 2007 Cannabinoid receptor agonists are mitochondrial inhibitors: a unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem. Biophys. Res. Commun. 364, 131-137. (doi:10.1016/j.bbrc.2007.09.107)
176. Benard, G. et al. 2012 Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat. Neurosci. 15, 558-564. (doi:10.1038/nn.3053)
177. Chiu, P., Karler, R., Craven, C., Olsen, D. M. & Turkanis, S. A. 1975 The influence of D9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption. Res. Commun. Chem. Pathol. Pharmacol. 12, 267-286.
178. Zaccagnino, P., Corcelli, A., Baronio, M. & Lorusso, M. 2011 Anandamide inhibits oxidative phosphorylation in isolated liver mitochondria. FEBS Lett. 585, 429-434. (doi:10.1016/j.febslet.2010.12.032)
179. Costa, B. & Colleoni, M. 2000 Changes in rat brain energetic metabolism after exposure to anandamide or D(9)-tetrahydrocannabinol. Eur. J. Pharmacol. 395, 1-7. (doi:10.1016/S0014-2999(00)00170-9)
180. Velez-Pardo, C., Jimenez-Del-Rio, M., Lores-Arnaiz, S. & Bustamante, J. 2010 Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure. Neurochem. Res. 35, 1323-1332. (doi:10.1007/s11064-010-0188-1)
181. Zaccagnino, P., D'Oria, S., Romano, L. L., di Venere A., Sardanelli, A. M. & Lorusso, M. 2012 The endocannabinoid 2-arachidonoylglicerol decreases calcium induced cytochrome c release from liver mitochondria. J. Bioenerg. Biomembr. 44, 273-280. (doi:10.1007/s10863-012-9431-6)
182. Germain, N., Boichot, E., Advenier, C., Berdyshev, E. V. & Lagente, V. 2002 Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-a production by human mononuclear cells. Int. Immunopharmacol. 2, 537-543. (doi:10.1016/S1567-5769(01)00200-4)
183. Atwood, B. K. & Mackie, K. 2010 CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol. 160, 467-479. (doi:10.1111/j.1476-5381.2010.00729.x)
184. Lou, Z. Y., Chen, C., He, Q., Zhao, C. B. & Xiao, B. G. 2011 Targeting CB(2) receptor as a neuroinflammatory modulator in experimental autoimmune encephalomyelitis. Mol. Immunol. 49, 453-461. (doi:10.1016/j.molimm.2011.09.016)
185. Stella, N. 2009 Endocannabinoid signaling in microglial cells. Neuropharmacology 56(Suppl. 1), 244-253. (doi:10.1016/j.neuropharm.2008.07.037)
186. Stella, N. 2010 Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas. Glia 58, 1017-1030. (doi:10.1002/glia.20983)
187. Racz, I. et al. 2008 Crucial role of CB(2) cannabinoid receptor in the regulation of central immune responses during neuropathic pain. J. Neurosci. 28, 12125-12135. (doi:10.1523/JNEUROSCI.3400-08.2008)
188. Palazuelos, J. et al. 2009 Microglial CB2. cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity. Brain 132, 3152-3164. (doi:10.1093/brain/awp239)
189. Walter, L., Franklin, A., Witting, A., Moller, T. & Stella, N. 2002 Astrocytes in culture produce anandamide and other acylethanolamides. J. Biol. Chem. 277, 20869-20876. (doi:10.1074/jbc.M110813200)
190. Witting, A., Walter, L., Wacker, J., Moller, T. & Stella, N. 2004 P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc. Natl Acad. Sci. USA 101, 3214-3219. (doi:10.1073/pnas.0306707101)
191. Muccioli, G.G. & Stella, N. 2008 Microglia produce and hydrolyze palmitoylethanolamide. Neuropharmacology 54, 16-22. (doi:10.1016/j.neuropharm.2007.05.015)
192. Carrier, E. J., Kearn, C. S., Barkmeier, A. J., Breese, N. M., Yang, W., Nithipatikom, K., Pfister, S. L., Campbell, W. B. & Hillard, C. J. 2004 Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Mol. Pharmacol. 65, 999-1007. (doi:10.1124/mol.65.4.999)
193. Muccioli, G. G., Xu, C., Odah, E., Cudaback, E., Cisneros, J. A., Lambert, D. M., Lopez Rodriguez, M. L., Bajjalieh, S. & Stella, N. 2007 Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J. Neurosci. 27, 2883-2889. (doi:10.1523/JNEUROSCI.4830-06.2007)
194. Walter, L., Dinh, T. & Stella, N. 2004 ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J. Neurosci. 24, 8068-8074. (doi:10.1523/JNEUROSCI.2419-04.2004)
195. Eljaschewitsch, E. et al. 2006 The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79. (doi:10.1016/j.neuron.2005.11.027)
196. Navarrete, M. & Araque, A. 2008 Endocannabinoids mediate neuron-astrocyte communication. Neuron 57, 883-893. (doi:10.1016/j.neuron.2008.01.029)
197. Albayram, O. et al. 2011 Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging. Proc. Natl Acad. Sci. USA 108, 11256-11261. (doi:10.1073/pnas.1016442108)
198. Mulder, J. et al. 2011 Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 134, 1041-1060. (doi:10.1093/brain/awr046)
199. Cosenza-Nashat, M. A., Bauman, A., Zhao, M. L., Morgello, S., Suh, H. S. & Lee, S. C. 2011 Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities. Neuropathol. Appl. Neurobiol. 37, 464-483. (doi:10.1111/j.1365-2990.2011.01177.x)
200. Tham, C. S., Whitaker, J., Luo, L. & Webb, M. 2007 Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators. FEBS Lett. 581, 2899-2904. (doi:10.1016/j.febslet.2007.05.037)
201. Ortega-Gutierrez, S., Molina-Holgado, E. & Guaza, C. 2005 Effect of anandamide uptake inhibition in the production of nitric oxide and in the release of cytokines in astrocyte cultures. Glia 52, 163-168. (doi:10.1002/glia.20229)
202. Sheng, W. S., Hu, S., Min, X., Cabral, G. A., Lokensgard, J. R. & Peterson, P. K. 2005 Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia 49, 211-219. (doi:10.1002/glia.20108)
203. Romero-Sandoval, E. A., Horvath, R., Landry, R. P. & DeLeo, J. A. 2009 Cannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation. Mol. Pain 5, 25. (doi:10.1186/1744-8069-5-25)
204. van der Stelt, M., Veldhuis, W. B., Maccarrone, M., Bar, P. R., Nicolay, K., Veldink, G. A., di Marzo, V. & Vliegenthart, J. F. 2002 Acute neuronal injury, excitotoxicity, and the endocannabinoid system. Mol. Neurobiol. 26, 317-346. (doi:10.1385/MN:26:2-3:317)
205. Tapia-Arancibia, L., Aliaga, E., Silhol, M. & Arancibia, S. 2008 New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 59, 201-220. (doi:10.1016/j.brainresrev.2008.07.007)
206. Zeng, Y., Tan, M., Kohyama, J., Sneddon, M., Watson, J. B., Sun, Y. E. & Xie, C.-W. 2011 Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J. Neurosci. 31, 17800-17810. (doi:10.1523/JNEUROSCI.3878-11.2011)
207. Grigorenko, E. et al. 2002 Assessment of cannabinoid induced gene changes: tolerance and neuroprotection. Chem. Phys. Lipids 121, 257-266. (doi:10.1016/S0009-3084(02)00161-5)
208. Butovsky, E., Juknat, A., Goncharov, I., Elbaz, J., Eilam, R., Zangen, A. & Vogel, Z. 2005 In vivo up-regulation of brain-derived neurotrophic factor in specific brain areas by chronic exposure to D-tetrahydrocannabinol. J. Neurochem. 93, 802-811. (doi:10.1111/j.1471-4159.2005.03074.x)
209. Marsicano, G. et al. 2003 CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302, 84-88. (doi:10.1126/science.1088208)
210. Derkinderen, P., Valjent, E., Toutant, M., Corvol, J. C., Enslen, H., Ledent, C., Trzaskos, J., Caboche, J. & Girault, J. A. 2003 Regulation of extracellular signalregulated kinase by cannabinoids in hippocampus. J. Neurosci. 23, 2371-2382.
211. Berghuis, P. et al. 2005 Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl Acad. Sci. USA 102, 19115-19120. (doi:10.1073/pnas.0509494102)
212. Aso, E., Ozaita, A., Valdizan, E. M., Ledent, C., Pazos, A., Maldonado, R. & Valverde, O. 2008 BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice. J. Neurochem. 105, 565-572. (doi:10.1111/j.1471-4159.2007.05149.x)
213. D'Souza, D. C., Pittman, B., Perry, E. & Simen, A. 2009 Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans. Psychopharmacology (Berl.) 202, 569-578. (doi:10.1007/s00213-008-1333-2)
214. Aguado, T. et al. 2005 The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19, 1704-1706.
215. Goncalves, M. B. et al. 2008 A diacylglycerol lipase- CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol. Cell Neurosci. 38, 526-536. (doi:10.1016/j.mcn.2008.05.001)
216. Marchalant, Y., Brothers, H. M. & Wenk, G. L. 2009 Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Mol. Psychiatry 14, 1068-1069. (doi:10.1038/mp.2009.62)
217. Hill, M. N., Kambo, J. S., Sun, J. C., Gorzalka, B. B. & Galea, L. A. 2006 Endocannabinoids modulate stress-induced suppression of hippocampal cell proliferation and activation of defensive behaviours. Eur. J. Neurosci. 24, 1845-1849. (doi:10.1111/j.1460-9568.2006.05061.x)
218. Oudin, M. J., Hobbs, C. & Doherty, P. 2011 DAGLdependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. Eur. J. Neurosci. 34, 1634-1646. (doi:10.1111/j.1460-9568.2011.07831.x)
219. Mulder, J. et al. 2008 Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl Acad. Sci. USA 105, 8760-8765. (doi:10.1073/pnas.0803545105)
220. Aguado, T., Romero, E., Monory, K., Palazuelos, J., Sendtner, M., Marsicano, G., Lutz, B., Guzman, M. & Galve-Roperh, I. 2007 The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. J. Biol. Chem. 282, 23892-23898. (doi:10.1074/jbc.M700678200)
221. Jin, K., Xie, L., Kim, S. H., Parmentier-Batteur, S., Sun, Y., Mao, X. O., Childs, J. & Greenberg, D. A. 2004 Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. Mol. Pharmacol. 66, 204-208. (doi:10.1124/mol.66.2.204)
222. Berrendero, F., Romero, J., Garcia-Gil, L., Suarez, I., De la Cruz, P., Ramos, J. A. & Fernandez-Ruiz, J. J. 1998 Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats. Biochim. Biophys. Acta 1407, 205-214. (doi:10.1016/S0925-4439(98)00042-8)
223. Romero, J., Berrendero, F., Garcia-Gil, L., de la Cruz, P., Ramos, J. A. & Fernandez-Ruiz, J. J. 1998 Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl- 50O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience 84, 1075-1083. (doi:10.1016/S0306-4522(97)00552-6)
224. Canas, P. M., Duarte, J. M., Rodrigues, R. J., Kofalvi, A. & Cunha, R. A. 2009 Modification upon aging of the density of presynaptic modulation systems in the hippocampus. Neurobiol. Aging 30, 1877-1884. (doi:10.1016/j.neurobiolaging.2008.01.003)
225. Liu, P., Bilkey, D. K., Darlington, C. L. & Smith, P. F. 2003 Cannabinoid CB1 receptor protein expression in the rat hippocampus and entorhinal, perirhinal, postrhinal and temporal cortices: regional variations and age-related changes. Brain Res. 979, 235-239. (doi:10.1016/S0006-8993(03)02872-5)
226. Wang, L., Liu, J., Harvey-White, J., Zimmer, A. & Kunos, G. 2003 Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl Acad. Sci. USA 100, 1393-1398. (doi:10.1073/pnas.0336351100)
227. Van Laere, K., Goffin, K., Casteels, C., Dupont, P., Mortelmans, L., de Hoon, J. & Bormans, G. 2008 Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 39, 1533-1541. (doi:10.1016/j.neuroimage.2007.10.053)
228. Maccarrone, M., Attina, M., Bari, M., Cartoni, A., Ledent, C. & Finazzi-Agro, A. 2001 Anandamide degradation and N-acylethanolamines level in wildtype and CB1 cannabinoid receptor knockout mice of different ages. J. Neurochem. 78, 339-348. (doi:10.1046/j.1471-4159.2001.00413.x)
229. Maccarrone, M., Valverde, O., Barbaccia, M. L., Castane, A., Maldonado, R., Ledent, C., Parmentier, M. & Finazzi-Agro, A. 2002 Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour. Eur. J. Neurosci. 15, 1178-1186. (doi:10.1046/j.1460-9568.2002.01957.x)
230. Buczynski, M.W. & Parsons, L. H. 2010 Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br. J. Pharmacol. 160, 423-442. (doi:10.1111/j.1476-5381.2010.00787.x)
231. Reibaud, M., Obinu, M. C., Ledent, C., Parmentier, M., Bohme, G. A. & Imperato, A. 1999 Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur. J. Pharmacol. 379, R1-R2. (doi:10.1016/S0014-2999(99)00496-3)
232. Bilkei-Gorzo, A., Racz, I., Valverde, O., Otto, M., Michel, K., Sastre, M. & Zimmer, A. 2005 Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl Acad. Sci. USA 102, 15670-15675. (doi:10.1073/pnas.0504640102)
233. Bohme, G. A., Laville, M., Ledent, C., Parmentier, M. & Imperato, A. 2000 Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience 95, 5-7. (doi:10.1016/S0306-4522(99)00483-2)
234. Di Marzo, V. 2011 Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat. Neurosci. 14, 9-15. (doi:10.1038/nn.2720)
235. Batkai, S., Rajesh, M., Mukhopadhyay, P., Hasko, G., Liaudet, L., Cravatt, B. F., Csiszar, A., Ungvari, Z. & Pacher, P. 2007 Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am. J. Physiol. Heart Circ. Physiol. 293, H909-H918. (doi:10.1152/ajpheart.00373.2007)
236. Moore, N. L., Greenleaf, A. L., Acheson, S. K., Wilson, W. A., Swartzwelder, H. S. & Kuhn, C. M. 2010 Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats. J. Pharmacol. Exp. Ther. 335, 294-301. (doi:10.1124/jpet.110.169359)
237. Trezza, V., Cuomo, V. & Vanderschuren, L. J. 2008 Cannabis and the developing brain: insights from behavior. Eur. J. Pharmacol. 585, 441-452. (doi:10.1016/j.ejphar.2008.01.058)
238. Nahas, G. & Latour, C. 1992 The human toxicity of marijuana. Med. J. Austr. 156, 495-497.
239. Paradisi, A., Oddi, S. & Maccarrone, M. 2006 The endocannabinoid system in ageing: a new target for drug development. Curr. Drug Targets 7, 1539-1552.
240. Marchalant, Y., Brothers, H. M. & Wenk, G. L. 2008 Inflammation and aging: can endocannabinoids help? Biomed. Pharmacother. 62, 212-217. (doi:10.1016/j.biopha.2008.02.004)
241. Bisogno, T. & Di Marzo, V. 2010 Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders. CNS Neurol. Disord. Drug Targets 9, 564-573.
242. Micale, V., Mazzola, C. & Drago, F. 2007 Endocannabinoids and neurodegenerative diseases. Pharmacol. Res. 56, 382-392. (doi:10.1016/j.phrs.2007.09.008)
243. Fernandez-Ruiz, J. 2009 The endocannabinoid system as a target for the treatment of motor dysfunction. Br. J. Pharmacol. 156, 1029-1040. (doi:10.1111/j.1476-5381.2008.00088.x)
244. Fernandez-Ruiz, J., Garcia, C., Sagredo, O., Gomez-Ruiz, M. & de Lago, E. 2010 The endocannabinoid system as a target for the treatment of neuronal damage. Expert Opin. Ther. Targets 14, 387-404. (doi:10.1517/14728221003709792)
245. Karl, T., Cheng, D., Garner, B. & Arnold, J. C. 2012 The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opin. Ther. Targets 16, 407-420. (doi:10.1517/14728222.2012.671812)
246. Ramirez, B. G., Blazquez, C., Gomez del Pulgar, T., Guzman, M. & de Ceballos, M. L. 2005 Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J. Neurosci. 25, 1904-1913. (doi:10.1523/JNEUROSCI.4540-04.2005)
247. Martin-Moreno, A. M. et al. 2012 Prolonged oral cannabinoid administration prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in Tg APP 2576 mice. J. Neuroinflammation 9, 8. (doi:10.1186/1742-2094-9-8)
248. Aso, E., Palomer, E., Juves, S., Maldonado, R., Munoz, F. J. & Ferrer, I. 2012 CB1 agonist ACEA protects neurons and reduces the cognitive impairment of AbetaPP/ PS1 mice. J. Alzheimer's Dis. 30, 439-459.
249. Walther, S., Mahlberg, R., Eichmann, U. & Kunz, D. 2006 D-9-tetrahydrocannabinol for nighttime agitation in severe dementia. Psychopharmacology (Berl.) 185, 524-528. (doi:10.1007/s00213-006-0343-1)
250. Carroll, C. B., Zeissler, M. L., Hanemann, C. O. & Zajicek, J. P. 2012 D(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease. Neuropathol. Appl. Neurobiol. (doi:10.1111/j.1365-2990.2011.01248.x)
251. Chung, E. S., Bok, E., Chung, Y. C., Baik, H. H. & Jin, B. K. 2012 Cannabinoids prevent lipopolysaccharideinduced neurodegeneration in the rat substantia nigra in vivo through inhibition of microglial activation and NADPH oxidase. Brain Res. 1451, 110-116. (doi:10.1016/j.brainres.2012.02.058)
252. Sieradzan, K. A., Fox, S. H., Hill, M., Dick, J. P., Crossman, A. R. & Brotchie, J. M. 2001 Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 57, 2108-2111. (doi:10.1212/WNL.57.11.2108)
253. Carroll, C. B. et al. 2004 Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study. Neurology 63, 1245-1250. (doi:10.1212/01.WNL.0000140288.48796.8E)
254. Mesnage, V. et al. 2004 Neurokinin, B., neurotensin, and cannabinoid receptor antagonists and Parkinson disease. Clin. Neuropharmacol. 27, 108-110. (doi:10.1097/00002826-200405000-00003)
255. Bilsland, L. G. & Greensmith, L. 2008 The endocannabinoid system in amyotrophic lateral sclerosis. Curr. Pharm. Des. 14, 2306-2316. (doi:10.2174/138161208785740081)
256. Pazos, M. R., Sagredo, O. & Fernandez-Ruiz, J. 2008 The endocannabinoid system in Huntington's disease. Curr. Pharm. Des. 14, 2317-2325. (doi:10.2174/138161208785740108)
257. Sagredo, O., Pazos, M. R., Satta, V., Ramos, J. A., Pertwee, R. G. & Fernandez-Ruiz, J. 2011 Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease. J. Neurosci. Res. 89, 1509-1518. (doi:10.1002/jnr.22682)
258. Blazquez, C. et al. 2011 Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease. Brain 134, 119-136. (doi:10.1093/brain/awq278)
259. Arevalo-Martin, A., Vela, J. M., Molina-Holgado, E., Borrell, J. & Guaza, C. 2003 Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J. Neurosci. 23, 2511-2516.
260. Bilsland, L. G., Dick, J. R., Pryce, G., Petrosino, S., Di Marzo, V., Baker, D. & Greensmith, L. 2006 Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice. FASEB J. 20, 1003-1005. (doi:10.1096/fj.05-4743fje)
261. Ramil, E. et al. 2010 The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain. Mult. Scler. 16, 139-146. (doi:10.1177/1352458509355071)
262. Rog, D. J., Nurmikko, T. J., Friede, T. & Young, C. A. 2005 Randomized, controlled trial of cannabisbased medicine in central pain in multiple sclerosis. Neurology 65, 812-819. (doi:10.1212/01.wnl.0000176753.45410.8b)
263. Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A. & Thompson, A. 2003 Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo-controlled trial. Lancet 362, 1517-1526. (doi:10.1016/S0140-6736(03)14738-1)
264. Collin, C., Davies, P., Mutiboko, I. K. & Ratcliffe, S. 2007 Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur. J. Neurol. 14, 290-296. (doi:10.1111/j.1468-1331.2006.01639.x)
265. Lakhan, S. E. & Rowland, M. 2009 Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurol. 9, 59-10. (doi:10.1186/1471-2377-9-59)
266. Wade, D. T., Makela, P. M., House, H., Bateman, C. & Robson, P. 2006 Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult. Scler. 12, 639-645. (doi:10.1177/1352458505070618